A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers (COVID-Milit)

Ajili et al., NCT04377646, COVID-Milit, NCT04377646, Jul 2020
Zinc for COVID-19
2nd treatment shown to reduce risk in July 2020, now with p = 0.00000028 from 47 studies, recognized in 23 countries.
No treatment is 100% effective. Protocols combine treatments.
6,200+ studies for 200+ treatments. c19early.org
Estimated 660 participant zinc prophylaxis RCT with results not reported over 5 years after estimated completion.
4 zinc RCTs have results missing long after expected1-4
The trials report a total of 900 patients, with 1 trial having actual enrollment of 150, and the remainder estimated.
Study covers HCQ and zinc.
Ajili et al., 31 Jul 2020, Double Blind Randomized Controlled Trial, placebo-controlled, trial NCT04377646 (history) (COVID-Milit). Contact: faida1977@yahoo.fr, nejlastam@gmail.com.
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit